Criteo SA
NASDAQ:CRTO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Criteo SA
NASDAQ:CRTO
|
FR |
|
A
|
Aclara Resources Inc
TSX:ARA
|
CL |
|
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
|
US |
|
B
|
Berkshire Hathaway Inc
SWB:BRH
|
US |
|
N
|
Nomura Holdings Inc
F:NSE
|
JP |
|
Hudbay Minerals Inc
TSX:HBM
|
CA |
|
E
|
ELEVAI Labs Inc
NASDAQ:ELAB
|
US |
|
Aspen (Group) Holdings Ltd
SGX:1F3
|
SG |
|
Sage Group PLC
LSE:SGE
|
UK |
Wall St Price Targets
CRTO Price Targets Summary
Criteo SA
According to Wall Street analysts, the average 1-year price target for CRTO is 25.13 USD with a low forecast of 16.16 USD and a high forecast of 36.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRTO's stock price target?
Price Target
25.13
USD
According to Wall Street analysts, the average 1-year price target for CRTO is 25.13 USD with a low forecast of 16.16 USD and a high forecast of 36.75 USD.
What is the Revenue forecast for Criteo SA?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 5 years is -9%.
What is the Operating Income forecast for Criteo SA?
Projected CAGR
-30%
Over the last 13 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 5 years is -30%.
What is the Net Income forecast for Criteo SA?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Net Income has been 44%. The projected CAGR for the next 5 years is -6%.
